Replies to post #242 on Ocular Therapeutix Inc (OCUL)

[Number sleven]

Kiwi, Stay safe. The acceleration of enrollment in the ocular wet-amd trials is why I'm thinking about trading. From what I have read I think the eye point drug is better. Doesn't actually matter to me. Looking for a shift from eypt to ocular after the phase 2 results.
Sleven,

[Number sleven]

Kiwi, Just to be clear, I don't care who has the better drug. In this case I'm only interested in market reaction and timing. Looking to go from eypt to ocular and back to eypt.
Sleven,

[Number sleven]

Kiwi, I think there might be a good play moving between the two companies. Thoughts?
Sleven,